These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 383285
1. Toxicity of intrapleural Bacillus Calmette-Guérin treatment in animals. Filardi MJ, Codish SD, Civerchia L, Howard RK, McKneally MF. Cancer Res; 1979 Sep; 39(9):3673-6. PubMed ID: 383285 [Abstract] [Full Text] [Related]
2. Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer. Bennett JA, Gruft H, McKneally MF, Zelterman D, Crispen RG. Cancer Res; 1983 Sep; 43(9):4183-90. PubMed ID: 6347367 [Abstract] [Full Text] [Related]
3. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma. Liotta LA, Kleinerman J, Saidel GM. Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897 [Abstract] [Full Text] [Related]
4. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity. Shapiro A, Ratliff TL, Oakley DM, Catalona WJ. Cancer Res; 1983 Apr; 43(4):1611-5. PubMed ID: 6339040 [Abstract] [Full Text] [Related]
5. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy. Vaage J. Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431 [Abstract] [Full Text] [Related]
6. Effect of a single exposure to ultraviolet radiation on Mycobacterium bovis bacillus Calmette-Guerin infection in mice. Jeevan A, Kripke ML. J Immunol; 1989 Nov 01; 143(9):2837-43. PubMed ID: 2681417 [Abstract] [Full Text] [Related]
7. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase. Sparks FC, Breeding JH. Cancer Res; 1974 Dec 01; 34(12):3262-9. PubMed ID: 4471640 [No Abstract] [Full Text] [Related]
8. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice. Kramnik I, Radzioch D, Skamene E. Immunology; 1994 Apr 01; 81(4):618-25. PubMed ID: 8039813 [Abstract] [Full Text] [Related]
9. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG). Campos MM, Henriques MG, Calixto JB. Br J Pharmacol; 1997 Feb 01; 120(3):502-8. PubMed ID: 9031756 [Abstract] [Full Text] [Related]
10. Effect of Bacillus Calmette-Guérin on the development of primary lung cancer in Syrian golden hamsters. Zwilling BS, Davis GW. Cancer Res; 1980 Oct 01; 40(10):3455-8. PubMed ID: 7002286 [Abstract] [Full Text] [Related]
12. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group. Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ. Semin Urol Oncol; 1996 Feb 01; 14(1 Suppl 1):10-6. PubMed ID: 8727805 [Abstract] [Full Text] [Related]
13. Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guerin in human macrophages and in mice. Bottai D, Esin S, Batoni G, Pardini M, Maisetta G, Donati V, Favilli F, Florio W, Campa M. Res Microbiol; 2005 Apr 01; 156(3):393-402. PubMed ID: 15808944 [Abstract] [Full Text] [Related]
14. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice. Kohama H, Umemura M, Okamoto Y, Yahagi A, Goga H, Harakuni T, Matsuzaki G, Arakawa T. Vaccine; 2008 Feb 13; 26(7):924-32. PubMed ID: 18192091 [Abstract] [Full Text] [Related]
15. Effectivity of living and non-living BCG vaccine on experimental metastatic spread in mice and the stimulation of the reticulohistiocytic system (RHS). Arnold W, Fey F, Graffi A. Neoplasma; 1981 Feb 13; 28(5):549-54. PubMed ID: 7312074 [Abstract] [Full Text] [Related]
16. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin. Ratliff TL, Palmer JO, McGarr JA, Brown EJ. Cancer Res; 1987 Apr 01; 47(7):1762-6. PubMed ID: 3545453 [Abstract] [Full Text] [Related]
17. Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology. Tree JA, Williams A, Clark S, Hall G, Marsh PD, Ivanyi J. Clin Exp Immunol; 2004 Dec 01; 138(3):405-9. PubMed ID: 15544615 [Abstract] [Full Text] [Related]
18. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis. Clark S, Cross ML, Smith A, Court P, Vipond J, Nadian A, Hewinson RG, Batchelor HK, Perrie Y, Williams A, Aldwell FE, Chambers MA. Vaccine; 2008 Oct 29; 26(46):5791-7. PubMed ID: 18789366 [Abstract] [Full Text] [Related]
19. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis. Castañon-Arreola M, López-Vidal Y, Espitia-Pinzón C, Hernández-Pando R. Tuberculosis (Edinb); 2005 Oct 29; 85(1-2):115-26. PubMed ID: 15687035 [Abstract] [Full Text] [Related]
20. Influence of immunisation with Mycobacterium bovis bacillus Calmette-Guérin on the sensitisation to inhaled allergens after infection with respiratory syncytial virus. Vonberg RP, Mueller M, Emmendoerffer A, Freihorst J. Clin Exp Med; 2005 Dec 29; 5(4):177-83. PubMed ID: 16362797 [Abstract] [Full Text] [Related] Page: [Next] [New Search]